Biography and Education
The research of Lan Yue, PhD, focuses on developing novel approaches to restore sight to the blind and decoding the underlying biological mechanisms. Dr. Yue has worked closely with patients who have received the retinal prostheses Argus I and II to evaluate the safety and efficacy of chronic electrical stimulation of the retina. Dr. Yue is committed to advancing the bioelectronic retinal prosthesis technologies and is concurrently developing minimally invasive alternatives to improve the visual experience of patients who are blind. Dr. Yue’s current effort involves using nano-sized neuro-photoswitches and novel optoelectronic materials in the optical control of the retinal activity as the building blocks of the next generation retinal prosthesis. Dr. Yue is also pursuing translational research in bioelectronics and biophotonics for the treatment of a variety of debilitating neurological diseases such as traumatic brain injury.
- University of Science and Technology of China, Electronic Engineering, BS, 2006
- University of Illinois at Chicago, Biomedical Engineering, PhD, 2012
- University of Southern California, Postdoctoral Fellow, 2013-2016
- ARVO/Retina Research Foundation/Lawrence Travel Fellowship Grant, 2011
- The Juliette RP Vision Foundation Young Scientist Award, 2016
- Yue L, Weiland JD, Roska B, Humayun MS. Retinal stimulation strategies to restore vision: fundamentals and systems. Prog Retin Eye Res. 2016 Jul; 53:21-47.
- Yue L, Falabella P, Christopher P, Wuyyuru V, Dorn J, Schor P, Greenberg RJ, Weiland JD, Humayun MS. Ten-year follow-up of a blind patient chronically implanted with epiretinal prosthesis Argus® I. Ophthalmology. 2015 Dec;122(12):2545-52.
- Yue L, Humayun MS. Monte Carlo analysis of the enhanced transcranial penetration using distributed near-infrared emitter array. J. Biomed. Opt. 20(8), 088001 (Aug 07, 2015).
- Yue L, Monge M, Ozgur M, Murphy K, Louie S, Miller C, Emami A, Humayun MS. Simulation and Measurement of Transcranial Near Infrared Light Penetration. Proc of SPIE BIOS Vol. 9321 93210S-1 (2015).
- Luo J, Lee SH, VandeVrede L, Qin Z, Piyankarage S, Tavassoli E, Asghedom RT, Alissa MB, Fa M, Arancio O, Yue L, Pepperberg DR & Thatcher, GR. Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia. BMC Neuroscience (2015).
- VandeVrede L, Tavassoli E, Luo J, Qin Z, Yue L, Pepperberg DR, Thatcher GR. Novel Analogues of Chlormethiazole are Neuroprotective in Four Cellular Models of Neurodegeneration by a Mechanism with Variable Dependence on GABAA Receptor Potentiation. Br J Pharmacol. 2014 Jan;171(2):389-402
- Yue L, Pawlowski M, Dellal SS, Xie A, Feng F, Otis TS, Bruzik KS, Qian H & Pepperberg DR. Robust photoregulation of GABAA receptors by allosteric modulation with a propofol analogue. Nov 26 2012 In: Nature Communications. 3, 1095
- Yue L, Xie A, Bruzik KS, Bente F, Qian H & Pepperberg DR. Potentiating action of propofol at GABAA receptors of retinal bipolar cells. Invest Ophthalmol Vis Sci. 2011 Apr;52(5):2497-2509.
- Xie A, Yan J, Yue L, Feng F, Mir F, Abdel-Halim H, Chebib M, Le Breton GC, Standaert RF, Qian H & Pepperberg DR. 2-aminoethyl methyl phosphonate (2-ATMP), a potent and rapidly acting antagonist of GABAA-ρ1 receptors. Mol Pharmacol. 2011 Dec;80(6):965-78.